Epigenomic Analysis of Sézary Syndrome Defines Patterns of Aberrant DNA Methylation and Identifies Diagnostic Markers
- 1 September 2016
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 136 (9) , 1876-1884
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The mutational landscape of cutaneous T cell lymphoma and Sézary syndromeNature Genetics, 2015
- Genomic landscape of cutaneous T cell lymphomaNature Genetics, 2015
- Functional normalization of 450k methylation array data improves replication in large cancer studiesGenome Biology, 2014
- A specific DNA methylation profile correlates with a high risk of disease progression in stage I classical (Alibert-Bazin type) mycosis fungoidesBritish Journal of Dermatology, 2014
- Genome-wide Analysis of Aberrant DNA Methylation for Identification of Potential Biomarkers in Colorectal Cancer PatientsAsian Pacific Journal of Cancer Prevention, 2012
- Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLLBlood, 2011
- Sézary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviorsBlood, 2010
- Leukaemogenesis: more than mutant genesNature Reviews Cancer, 2010
- Hypermethylation of a Small CpGuanine-Rich Region Correlates with Loss of Activator Protein-2α Expression during Progression of Breast CancerCancer Research, 2004
- Chromosomal Instability and Tumors Promoted by DNA HypomethylationScience, 2003